Q Fever News and Research

RSS

Study suggests that epigenetic memory in innate immune cells could be the key to explaining long COVID

A new study may provide a partial explanation for the long-term immunologic phenomena associated with COVID-19.

15 Feb 2022

Antihistamines may offer hope for long COVID patients

Researchers offer hope that an inexpensive over-the-counter medication could improve long COVID symptoms for a large proportion of these patients.

14 Feb 2022

Differences in infection with Omicron or Delta SARS-CoV-2 variants among vaccinated population from the UK

In a recent study, researchers demonstrated that COVID-19 symptoms varied between cases of SARS-CoV-2 Omicron and Delta variants of concern.

14 Feb 2022

The impact of COVID-19 on people with systemic autoimmune rheumatic diseases

A survey demonstrated that patients with systemic autoimmune rheumatic diseases commonly experience augmented disease severity and disrupted treatment regimens of disease-modifying antirheumatic drugs after acute COVID-19 course.

11 Feb 2022

New research confirms the safety of mRNA COVID-19 vaccines for people with cancer

New research in the February 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network confirms that mRNA vaccine for COVID-19 are just as safe for people with cancer as they are for cancer-free individuals.

10 Feb 2022

Comparison of SARS-CoV-2 test performance by sample type and modality in close contacts of SARS-CoV-2 cases

In this study, researchers looked at how well molecular and antigen testing performed in symptomatic and asymptomatic close contacts of SARS-CoV-2 positive people.

10 Feb 2022

Exploring omicron infection in COVID-19 vaccinated and convalescent South African healthcare workers

In a new study, researchers evaluated healthcare workers in South Africa, presenting with SARS-CoV-2 symptoms, for infection by the Omicron variant.

9 Feb 2022

Philippines starts vaccinating children aged five to 11 against COVID-19

The Philippines began vaccinating children aged five to 11 against COVID-19 on Monday after initial hiccups over delayed deliveries of the Pfizer-BioNTech doses and opposition to the drive by some parents.

9 Feb 2022

Association between SARS-CoV-2 infection and several key respiratory and non-respiratory complications

Researchers assessed the intensity of association between SARS-CoV-2 infection and risks of various respiratory and non-respiratory complications.

9 Feb 2022

UTSA awarded $6.8 million grant to establish a Coccidioidomycosis Collaborative Research Center

Mycology and immunology researchers from The University of Texas at San Antonio have been selected to receive a five-year, $6.8 million grant from the National Institutes of Health to establish a San Antonio-based Coccidioidomycosis Collaborative Research Center (SA-CCRC) focused on developing therapeutics and vaccines against coccidioidomycosis.

8 Feb 2022

Study explores SARS-CoV-2 manifestations and related hospitalizations in infants

A new study examined the clinical manifestations of SARS-CoV-2 infections, disease severity, and related hospitalization in infants in Canada.

8 Feb 2022

The impact of SARS-CoV-2 variants on clinical trajectory and outcome

The current study describes the results of examining a patient database to understand just how Omicron affected the clinical outcome.

8 Feb 2022

Impact of SARS-CoV-2 infection in pregnant women on maternal and perinatal outcomes

Researchers conducted a retrospective cohort analysis by reviewing medical records of pregnant women to examine the impact of SARS-CoV-2 maternal infection on maternal and perinatal outcomes.

8 Feb 2022

Fever the dominant symptom in SARS-CoV-2 Alpha- and Delta-infected children

Researchers assess the different clinical symptoms of SARS-CoV-2 infection in children and adolescents across different time periods.

7 Feb 2022

Paracetamol use increases blood pressure, study shows

Long-term paracetamol use could increase the risk of heart disease and strokes in people with high blood pressure, a study suggests.

7 Feb 2022

Colchicine holds promise to reduce the risk of severe COVID-19

A recent article, published in Rheumatology and Therapy, reviews the potent evidence of colchicine against the SARS-CoV-2 infection.

7 Feb 2022

Vaccine-induced immunity and prior infection effective in reducing COVID severity in reinfections

A recent study posted to the Research Square* preprint server and under consideration for inclusion in the journal Scientific Reports assessed the epidemiology of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) reinfections.

6 Feb 2022

Dizziness is a common symptom of COVID-19

New research published in Internal and Emergency Medicine discusses the relationship between SARS-CoV-2 infection and dizziness.

6 Feb 2022

Study assesses how vaccination against typhoid fever could help avert antimicrobial resistance

Researchers from Yale University, University of Basel, University of Antwerp, CDDEP and other institutions recently published 'Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modeling study' in The Lancet Infectious Diseases.

4 Feb 2022

Investigation of SARS-CoV-2 outbreak in UK office highlights the need for a site-specific COVID-19 prevention strategy

In a new study, researchers comprehensively investigated a public-facing office in England where a SARS-CoV-2 outbreak occurred during August-September 2021 to identify workplace and worker-related risk factors.

4 Feb 2022

Q Fever News and Research

Study suggests that epigenetic memory in innate immune cells could be the key to explaining long COVID

Antihistamines may offer hope for long COVID patients

Differences in infection with Omicron or Delta SARS-CoV-2 variants among vaccinated population from the UK

The impact of COVID-19 on people with systemic autoimmune rheumatic diseases

New research confirms the safety of mRNA COVID-19 vaccines for people with cancer

Comparison of SARS-CoV-2 test performance by sample type and modality in close contacts of SARS-CoV-2 cases

Exploring omicron infection in COVID-19 vaccinated and convalescent South African healthcare workers

Philippines starts vaccinating children aged five to 11 against COVID-19

Association between SARS-CoV-2 infection and several key respiratory and non-respiratory complications

UTSA awarded $6.8 million grant to establish a Coccidioidomycosis Collaborative Research Center

Study explores SARS-CoV-2 manifestations and related hospitalizations in infants

The impact of SARS-CoV-2 variants on clinical trajectory and outcome

Impact of SARS-CoV-2 infection in pregnant women on maternal and perinatal outcomes

Fever the dominant symptom in SARS-CoV-2 Alpha- and Delta-infected children

Paracetamol use increases blood pressure, study shows

Colchicine holds promise to reduce the risk of severe COVID-19

Vaccine-induced immunity and prior infection effective in reducing COVID severity in reinfections

Dizziness is a common symptom of COVID-19

Study assesses how vaccination against typhoid fever could help avert antimicrobial resistance

Investigation of SARS-CoV-2 outbreak in UK office highlights the need for a site-specific COVID-19 prevention strategy

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News